2019
DOI: 10.1016/j.pan.2019.05.278
|View full text |Cite
|
Sign up to set email alerts
|

Lymph Node Ratio as Valuable Predictor in Pancreatic Cancer Treated with R0 Resection and Adjuvant Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
14
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(15 citation statements)
references
References 0 publications
1
14
0
Order By: Relevance
“…and A.C.) independently evaluated each of the studies using the Newcastle-Ottawa scale. The information of the studies included in shown in Table 1 [ 2 - 4 , 7 , 9 - 18 ]. The study was designated to be of poor quality if it did not meet more than one of the criteria in the selection domain, no score in the compatibility domain, and did not meet more than one of the criteria in the outcome domain.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…and A.C.) independently evaluated each of the studies using the Newcastle-Ottawa scale. The information of the studies included in shown in Table 1 [ 2 - 4 , 7 , 9 - 18 ]. The study was designated to be of poor quality if it did not meet more than one of the criteria in the selection domain, no score in the compatibility domain, and did not meet more than one of the criteria in the outcome domain.…”
Section: Methodsmentioning
confidence: 99%
“…Prognostic impact of lymph nodal metastasis can be assessed by using various methods such as the presence of positive LNs, total number of LNs, ratio of positive to total LNs, and also ratio of positive to negative LNs [ 7 ]. It should be noted that considering the number of positive LN involved to categorize nodal disease and to predict prognosis has been inaccurate.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The presence of cancerous cells in the lymph node (LN) negatively correlates with patient survival in many cancer types ( Fortea-Sanchis et al., 2018 ; Pai et al., 2011 ; You et al., 2019 ). Yet as many as 45% of patients have LN involvement, and a startling 89% have disseminated tumor cells within their LNs in the context of colon and pancreatic cancers, respectively ( Weledji et al., 2016 ; Wong, 2009 ).…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, LNR has been considered as an independent prognostic predictor of survival in PDAC patients better than positive lymph nodes for patients after resection of pancreatic cancer [32][33][34].It is not surprising that LNR could be used to assess the survival of resected pancreatic SRCC. But at present, the role of LNR in predicting survival of resected pancreatic SRCC is unclear.…”
Section: Discussionmentioning
confidence: 99%